These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33219191)

  • 1. Cortical hyperostosis, rare adverse effect of prostaglandin.
    Ng RL; Koay HS; Jamil MT
    Med J Malaysia; 2020 Nov; 75(6):748-749. PubMed ID: 33219191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
    Nadroo AM; Shringari S; Garg M; al-Sowailem AM
    J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
    Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
    J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M; Muraoka R; Aoshima M; Nomoto S; Shiraishi Y; Kyoku I; Kitano M; Shimada I; Nakano H; Ueda K
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):399-403. PubMed ID: 4033176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classic Blalock-Taussig shunt in neonates.
    Yoshimura N; Yamaguchi M; Ohashi H; Oshima Y; Toyoda Y; Ogawa K
    J Cardiovasc Surg (Torino); 1999 Feb; 40(1):107-10. PubMed ID: 10221395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.
    McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
    Høst A; Halken S; Andersen PE
    Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts.
    Sivakumar K; Shivaprakasha K; Rao SG; Kumar RK
    Indian Heart J; 2001; 53(1):66-70. PubMed ID: 11456144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Reverse Blalock-Taussig shunt": application in single ventricle hybrid palliation.
    Baba K; Honjo O; Chaturvedi R; Lee KJ; Van Arsdell G; Caldarone CA; Benson LN
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):352-7. PubMed ID: 23228402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A five-year clinical experience with 112 Blalock-Taussig shunts.
    Gold JP; Violaris K; Engle MA; Klein AA; Ehlers KH; Lang SJ; Levin AR; Moran F; O'Loughlin JE; Snyder MS
    J Card Surg; 1993 Jan; 8(1):9-17. PubMed ID: 8422496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Blalock-Taussig shunt in infants: standard versus modified.
    Ullom RL; Sade RM; Crawford FA; Ross BA; Spinale F
    Ann Thorac Surg; 1987 Nov; 44(5):539-43. PubMed ID: 3675059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperostosis: an under-recognized complication of prostaglandin infusion.
    Abdelaziz M; John CM
    Acta Paediatr; 2013 May; 102(5):e192. PubMed ID: 23414095
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical results of combined palliative procedures for cyanotic congenital heart defects with intractable hypoplasia of pulmonary arteries.
    Fan XM; Zhu YB; Su JW; Zhang J; Li ZQ; Xu YQ; Li XF; Liu YL
    Chin Med J (Engl); 2013; 126(9):1678-82. PubMed ID: 23652050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blalock-Taussig shunts and modified Blalock-Taussig shunts.
    Sanchez HE; Vosloo S
    S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic-pulmonary shunts in infants and children. Early and late results.
    Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions Involving the Use of Covered Coronary Artery Stents for Pseudoaneurysms of Blalock-Taussig Shunts.
    Baspinar O; Sahin DA; Sulu A; Gokaslan G
    World J Pediatr Congenit Heart Surg; 2016 Jul; 7(4):494-7. PubMed ID: 26852366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of prostaglandin E1 and Blalock-Taussig shunts in neonates with cyanotic congenital heart disease.
    Browdie DA; Norberg W; Agnew R; Altenburg B; Ignacio R; Hamilton C
    Ann Thorac Surg; 1979 Jun; 27(6):508-13. PubMed ID: 454028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency transcatheter balloon recanalization of acutely thrombosed modified Blalock-Taussig shunts.
    Sivakumar K; Anil SR; Ravichandra M; Natarajan KU; Kamath P; Kumar RK
    Indian Heart J; 2001; 53(6):743-8. PubMed ID: 11838928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Blalock-Taussig shunt: simple but unpredictable.
    Dave HH
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):178-9. PubMed ID: 27032468
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive evaluation of Blalock-Taussig shunts: determination of patency and differentiation from patent ductus arteriosus by doppler echocardiography.
    Stevenson JG; Kawabori I; Bailey WW
    Am Heart J; 1983 Nov; 106(5 Pt 1):1121-32. PubMed ID: 6637769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.